Author information from the last article
Avdeling for blodsykdommer
Oslo universitetssykehus
og
Institutt for klinisk medisin
Universitetet i Oslo
Forfatterbidrag: tolkning av data, litteratursøk, revisjon og godkjenning av manusrevisjoner.
Geir Erland Tjønnfjord er overlege og professor emeritus.
Articles by Geir Erland Tjønnfjord
Allogeneic stem cell transplantation for patients with lymphoma 2011–21
- Hege Melby Frøen,
- Marianne Brodtkorb,
- Harald Holte,
- Arne Kolstad,
- Anders Eivind Myhre,
- Mats Remberger,
- Geir Erland Tjønnfjord,
- Tobias Gedde-Dahl
03.03.2025:
Allogeneic stem cell transplantation (ASCT) is potentially curative for patients with haematologic malignancies, lymphomas and certain non-malignant conditions. However, it carries a risk of severe complications and transplant-related mortality due to organ damage, infection and graft-versus-host...
Allogeneic stem cell transplantation in adults 2015–21
- Camilla Dao Vo,
- Anders Eivind Myhre,
- Ingerid Weum Abrahamsen,
- Mats Remberger,
- Jonas Mattsson,
- Yngvar Fløisand,
- Bjørn Christer Linder Grønvold,
- Geir Erland Tjønnfjord,
- Tor Henrik Anderson Tvedt,
- Tobias Gedde-Dahl
14.03.2023:
Allogeneic stem cell transplantation is the only curative treatment for a number of malignant haematological diseases and congenital or acquired immunodeficiencies. In allogeneic stem cell transplantation, the patient's own bone marrow is destroyed following pre-transplant treatment with high-dose...
Therapeutic complement inhibition – from experimental to clinical medicine
- Knut Tore Lappegård,
- Anna Bjerre,
- Geir Erland Tjønnfjord,
- Tom Eirik Mollnes
20.10.2015:
The complement system plays a central part in the body's infection defence mechanism, but it is also involved in tissue homeostasis generally. Undesirable activation of the system occurs in connection with a number of diseases, so inhibition of the complement system has become an interesting...
Patient knowledge of late effects of acute lymphoblastic leukaemia
- Ellen Ruud,
- Adriani Kanellopoulos,
- Bernward Zeller,
- Eva Widing,
- Geir Erland Tjønnfjord,
- Sophie Dorothea Fosså
02.10.2012:
Cancer in children is rare, and accounts for only 1 % of all cancer incidences in Norway (1). Care for children with cancer is special because the patient is growing and developing, and most have the prospect of a long life after curative cancer treatment. The prognosis for children with cancer is...